BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32877311)

  • 41. [Varicose veins. Chronic venous insufficiency. Lower limbs venous ulcers. Point of view].
    Becker F
    Rev Med Interne; 2004 Jan; 25(1):65-73. PubMed ID: 14736562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular mechanisms in chronic venous insufficiency.
    Bergan J
    Ann Vasc Surg; 2007 May; 21(3):260-6. PubMed ID: 17484957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease.
    Castro-Ferreira R; Cardoso R; Leite-Moreira A; Mansilha A
    Ann Vasc Surg; 2018 Jan; 46():380-393. PubMed ID: 28688874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing.
    Brown LF; Dubin D; Lavigne L; Logan B; Dvorak HF; Van de Water L
    Am J Pathol; 1993 Mar; 142(3):793-801. PubMed ID: 8456940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer.
    Raffetto JD; Mendez MV; Phillips TJ; Park HY; Menzoian JO
    Am J Surg; 1999 Aug; 178(2):107-12. PubMed ID: 10487259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipodermatosclerosis and the significance of proteolytic remodeling in the pathogenesis of venous ulceration (Review).
    Herouy Y; Nockowski P; Schöpf E; Norgauer J
    Int J Mol Med; 1999 May; 3(5):511-5. PubMed ID: 10202183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular matrix incorporation of normal and NEM-alkylated fibronectin: liver and spleen deposition.
    Rebres RA; McKeown-Longo PJ; Vincent PA; Cho E; Saba TM
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G902-12. PubMed ID: 8572222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers.
    Herrick SE; Sloan P; McGurk M; Freak L; McCollum CN; Ferguson MW
    Am J Pathol; 1992 Nov; 141(5):1085-95. PubMed ID: 1279979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomolecular mechanisms in varicose veins development.
    Segiet OA; Brzozowa-Zasada M; Piecuch A; Dudek D; Reichman-Warmusz E; Wojnicz R
    Ann Vasc Surg; 2015 Feb; 29(2):377-84. PubMed ID: 25449990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathophysiology and clinical aspects of the venous low-pressure system].
    Schneider W
    Hautarzt; 1979 Apr; 30(4):180-5. PubMed ID: 437977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of epidermal gap junctional proteins in patients with venous disease.
    Kanapathy M; Simpson R; Madden L; Thrasivoulou C; Mosahebi A; Becker DL; Richards T
    Br J Surg; 2018 Jan; 105(1):59-67. PubMed ID: 29143961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers.
    Lawrence PF; Alktaifi A; Rigberg D; DeRubertis B; Gelabert H; Jimenez JC
    J Vasc Surg; 2011 Sep; 54(3):737-42. PubMed ID: 21658887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin iron deposition characterises lipodermatosclerosis and leg ulcer.
    Caggiati A; Rosi C; Casini A; Cirenza M; Petrozza V; Acconcia MC; Zamboni P
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):777-82. PubMed ID: 20880725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways.
    Midwood KS; Schwarzbauer JE
    Mol Biol Cell; 2002 Oct; 13(10):3601-13. PubMed ID: 12388760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of dexamethasone on the assembly of the matrix of fibronectin and on its receptors organization in Ehlers-Danlos syndrome skin fibroblasts.
    Zoppi N; Ghinelli A; Gardella R; Barlati S; Colombi M
    Cell Biol Int; 1998; 22(7-8):499-508. PubMed ID: 10452818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of fibronectin isoforms in human renal disease.
    Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
    J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic impairment, venous segmental disease, and clinical severity scoring in limbs with Klippel-Trenaunay syndrome.
    Delis KT; Gloviczki P; Wennberg PW; Rooke TW; Driscoll DJ
    J Vasc Surg; 2007 Mar; 45(3):561-7. PubMed ID: 17275246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does air plethysmography correlate with duplex scanning in patients with chronic venous insufficiency?
    van Bemmelen PS; Mattos MA; Hodgson KJ; Barkmeier LD; Ramsey DE; Faught WE; Sumner DS
    J Vasc Surg; 1993 Nov; 18(5):796-807. PubMed ID: 8230566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin.
    Clark RA
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):128S-134S. PubMed ID: 2161886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteolysis of decellularized extracellular matrices results in loss of fibronectin and cell binding activity.
    Ramanathan A; Karuri N
    Biochem Biophys Res Commun; 2015 Apr; 459(2):246-251. PubMed ID: 25724944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.